Attached files

file filename
10-K - FORM 10-K - Amarantus Bioscience Holdings, Inc.v374510_10k.htm
EX-32.1 - EXHIBIT 32.1 - Amarantus Bioscience Holdings, Inc.v374510_ex32-1.htm
EX-21 - EXHIBIT 21 - Amarantus Bioscience Holdings, Inc.v374510_ex21.htm
EX-32.2 - EXHIBIT 32.2 - Amarantus Bioscience Holdings, Inc.v374510_ex32-2.htm
EX-10.45 - EXHIBIT 10.45 - Amarantus Bioscience Holdings, Inc.v374510_ex10-45.htm
EX-31.2 - EXHIBIT 31.2 - Amarantus Bioscience Holdings, Inc.v374510_ex31-2.htm
EX-31.1 - EXHIBIT 31.1 - Amarantus Bioscience Holdings, Inc.v374510_ex31-1.htm
EX-10.47 - EXHIBIT 10.47 - Amarantus Bioscience Holdings, Inc.v374510_ex10-47.htm
EX-10.48 - EXHIBIT 10.48 - Amarantus Bioscience Holdings, Inc.v374510_ex10-48.htm
EX-10.44 - EXHIBIT 10.44 - Amarantus Bioscience Holdings, Inc.v374510_ex10-44.htm
EX-23.2 - EXHIBIT 23.2 - Amarantus Bioscience Holdings, Inc.v374510_ex23-2.htm

 

Independent Registered Public Accounting Firm’s Consent

 

 

We consent to the incorporation by reference in the Registration Statements of Amarantus BioScience Holdings, Inc. on Form S-8 filed on November 30, 2011 (File No. 333-178222), March 1, 2013 (File No. 333-186995) and January 17, 2014 (File No. 333-193435) of our report, which includes an explanatory paragraph as to the Company’s ability to continue as a going concern, dated April 16, 2014 , with respect to our audit of the consolidated financial statements of Amarantus BioScience Holdings, Inc. as of December 31, 2013 and for the year then ended, which report is included in this Annual Report on Form 10-K of Amarantus BioScience Holdings, Inc. for the year ended December 31, 2013.

 

 

 

/s/ Marcum LLP

New York, NY

April 21, 2014